BioCentury
ARTICLE | Clinical News

Anti-CD19 chimeric antigen receptor: Phase I data

May 30, 2016 7:00 AM UTC

Data from 19 patients with various subtypes of DLBCL in an NIH-funded Phase I trial showed that a single infusion of anti- CD19 CAR T cells given 2 days after completion of low-dose conditioning chemo...